04.03.2022
![]()
Original-Research: ADVA Optical Networking SE (von First Berlin Equity Research GmbH): Kaufen
Original-Research: ADVA Optical Networking SE - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu ADVA Optical Networking SE Unternehmen: ADVA Optical Networking SE ISIN: DE0005103006 Anlass der Studie: Update First Berlin Equity Research hat ein Research Update zu ADVA Optical Networking SE (ISIN: DE0005103006) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 18,00 auf EUR 20,00. Zusammenfassung: First Berlin Equity Research has published a research update on ADVA Optical Networking SE (ISIN: DE0005103006). Analyst Simon Scholes reiterated his BUY rating and increased the price target from EUR 18.00 to EUR 20.00. At the end of January, ADVA announced that owners of more than 60% of its share capital had accepted the ADVA/ADTRAN merger. With this threshold crossed, the merger can now proceed subject to regulatory approval. The relevant US authorities have given permission for the transaction to take place, but final approval is still required in Germany. ADVA's management expect this to be forthcoming in Q2 or Q3 of this year. The proposed merger of ADVA and ADTRAN brings together two fibre optic edge networking specialists in the second year of an edge network investment boom. The shift towards home-based work and leisure caused by the COVID-19 pandemic acted as the initial trigger for accelerating investment at the network edge. US and European government funding of USD190bn in broadband infrastructure investment, the roll-out of 5G, the growth of the Internet of Things, the replacement of Huawei infrastructure, and the emergence of the metaverse look set to ensure that the boom continues without interruption until at least the end of this decade. Ahead of the merger completion both ADVA and ADTRAN have reported Q4/21 numbers which were above consensus expectations. The lower end of ADVA's 2022 sales guidance of €650m to €700m is also above our previous 2022 ADVA-standalone projection of €643m. We have reworked our forecasts and now project five year (2021-26) sales and adjusted EBITDA CAGRs for the merged entity of 11.2% and 26.7%, respectively (previously: 8.7% and 25.5% respectively). We expect sales growth to be fuelled by the demand drivers outlined above as well as by cross-selling opportunities estimated by management at $60m to $120m annually. The implied margin expansion stems from the eventual easing of the current components shortage, the ongoing shift in the sales mix towards higher margin customers and products, operating leverage, as well as cost synergies, which management estimates at $52m. We now see fair value for the ADVA share at €20.00 (previously: €18.00). We maintain our Buy recommendation. Bezüglich der Pflichtangaben gem. §85 Abs. 1 S. 1 WpHG und des Haftungsausschlusses siehe die vollständige Analyse. Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/23523.pdf Kontakt für Rückfragen -------------------übermittelt durch die EQS Group AG.------------------- Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. |